cAMP/PKA signaling pathway contributes to neuronal apoptosis via regulating IDE expression in a mixed model of type 2 diabetes and Alzheimer's disease

Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy

(2016) Haihua Yang et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues

(2015) Ekaterina G. Kochkina et al.   BIOGERONTOLOGY

Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease

(2015) Juan Jose Ramos-Rodriguez et al.   PSYCHONEUROENDOCRINOLOGY

Insulin-Degrading Enzyme: A Link Between Alzheimer’s and Type 2 Diabetes Mellitus

(2014) Rizwanul Haque et al.   CNS & Neurological Disorders-Drug Targets

AP4M1 is abnormally expressed in oxygen–glucose deprived hippocampal neurons

(2014) J. Zhang et al.   NEUROSCIENCE LETTERS

Regulation of Insulin Degrading Enzyme Activity by Obesity-Associated Factors and Pioglitazone in Liver of Diet-Induced Obese Mice

(2014) Xiuqing Wei et al.   PLoS One

Dual effect of cAMP agonist on ameliorative function of PKA inhibitor in morphine-dependent mice

(2013) Seyedeh Y. Seyedi et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Alzheimer's  -Secretase (BACE1) Regulates the cAMP/PKA/CREB Pathway Independently of  -Amyloid

(2012) Y. Chen et al.   JOURNAL OF NEUROSCIENCE

Upregulation of CREB-Mediated Transcription Enhances Both Short- and Long-Term Memory

(2011) A. Suzuki et al.   JOURNAL OF NEUROSCIENCE

Differential Effects of Scopolamine on Memory Processes in the Object Recognition Test and the Morris Water Maze Test in Mice

(2009) Dong-Hyun Kim et al.   Biomolecules & Therapeutics

SO2 inhalation induces protein oxidation, DNA–protein crosslinks and apoptosis in rat hippocampus

(2008) Nan Sang et al.   ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY